Abstract

Bovine respiratory disease continues to be the most costly disease affecting productivity and profitability in the stocker segment. Despite their high cost, longer-acting, injectable therapeutic antimicrobials such as Draxxin (Tulathromycin; Pfizer Animal Health, New York, NY) can extend the window of treatment duration, thereby reducing the incidence and severity of bovine respiratory disease. Use of feed-based metaphylaxis programs, such as therapeutic administration of multiple 5-day pulses of Aureomycin (αrma, Inc., Bridgewater, NJ), in conjunction with an injectable metaphylaxis program may be a cost-effective way to improve bovine respiratory disease therapy without having to physically handle and stress cattle.

Keywords: Cattlemen's Day, 2010, Kansas Agricultural Experiment Station contribution, no. 10-170-S, Report of progress (Kansas State University. Agricultural Experiment Station and Cooperative Extension Service), 1029, Beef Cattle Research, 2010 is known as Cattlemen's Day, Beef, Metaphylaxis, Performance, Draxxin

How to Cite:

Epp, M., Derstein, R. & Blasi, D. A., (2010) “Feed-based metaphylaxis programs did not affect health or performance of high-risk calves mass medicated with Draxxin on arrival”, Kansas Agricultural Experiment Station Research Reports 1(1), 26-28. doi: https://doi.org/10.4148/2378-5977.2877